SRx Health Solutions Statistics
Total Valuation
SRXH has a market cap or net worth of $36.83 million. The enterprise value is $43.75 million.
Important Dates
The next estimated earnings date is Thursday, March 26, 2026, after market close.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRXH has 298.21 million shares outstanding. The number of shares has increased by 90.87% in one year.
| Current Share Class | 298.21M |
| Shares Outstanding | 298.21M |
| Shares Change (YoY) | +90.87% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.36% |
| Owned by Institutions (%) | 0.24% |
| Float | 273.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.83 |
| Forward PS | n/a |
| PB Ratio | 10.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 5.97.
| Current Ratio | 0.80 |
| Quick Ratio | 0.68 |
| Debt / Equity | 5.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -337.57% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $849,182 |
| Profits Per Employee | -$4.51M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SRXH has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.35 |
| Relative Strength Index (RSI) | 43.76 |
| Average Volume (20 Days) | 30,485,875 |
Short Selling Information
The latest short interest is 8.15 million, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 8.15M |
| Short Previous Month | 3.55M |
| Short % of Shares Out | 2.73% |
| Short % of Float | 2.98% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, SRXH had revenue of $9.34 million and -$49.64 million in losses. Loss per share was -$2.10.
| Revenue | 9.34M |
| Gross Profit | 2.58M |
| Operating Income | -11.90M |
| Pretax Income | -17.25M |
| Net Income | -49.64M |
| EBITDA | -12.77M |
| EBIT | -11.90M |
| Loss Per Share | -$2.10 |
Full Income Statement Balance Sheet
The company has $13.06 million in cash and $21.03 million in debt, with a net cash position of -$7.97 million or -$0.03 per share.
| Cash & Cash Equivalents | 13.06M |
| Total Debt | 21.03M |
| Net Cash | -7.97M |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | 3.52M |
| Book Value Per Share | -0.11 |
| Working Capital | -4.69M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$21.05 million and capital expenditures $157,000, giving a free cash flow of -$20.89 million.
| Operating Cash Flow | -21.05M |
| Capital Expenditures | 157,000 |
| Free Cash Flow | -20.89M |
| FCF Per Share | -$0.07 |
Full Cash Flow Statement Margins
| Gross Margin | 27.62% |
| Operating Margin | -127.35% |
| Pretax Margin | -184.66% |
| Profit Margin | n/a |
| EBITDA Margin | -136.71% |
| EBIT Margin | -127.35% |
| FCF Margin | n/a |
Dividends & Yields
SRXH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -90.87% |
| Shareholder Yield | n/a |
| Earnings Yield | -138.71% |
| FCF Yield | -58.39% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRXH has an Altman Z-Score of -2.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 3 |